Lead Sponsor

Eli Lilly and Company

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

•Have a clinical diagnosis of type 1 diabetes for at least 1 year prior to screening
•Have received treatment with basal-bolus insulin analog multiple daily injection therapy according to the local product label for at least 90 days prior to screening
•Have an HbA1c value of 7.0% to 10.0%, inclusive, as determined by the central laboratory at screening.
•Have a body mass index of ≤35 kilogram/square meter (kg/m²)

•Have a diagnosis of type 2 diabetes, latent autoimmune diabetes, or specific types of diabetes other than type 1 diabetes
•Have a history of more than 1 episode of severe hypoglycemia, within the 6 months prior to screening.
•Have a history of more than 1 episode of diabetic ketoacidosis or hyperosmolar state or coma requiring hospitalization within the 6 months prior to screening.